LYMPHOCYTIC LEUKEMIA
Clinical trials for LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to wipe out hidden leukemia cells
Disease control Not yet recruitingThis phase 2 trial tests the drug mosunetuzumab in 30 people with chronic lymphocytic leukemia (CLL) who still have detectable cancer cells after at least six months of standard therapy. The goal is to see if the drug can clear those remaining cells and improve outcomes. Particip…
Matched conditions: LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 02, 2026 04:00 UTC
-
In-Body CAR-T: could this be the future of blood cancer treatment?
Disease control Not yet recruitingThis early-phase trial tests a new type of CAR-T therapy for B-cell blood cancers like lymphoma and leukemia. Instead of removing a patient's immune cells, modifying them in a lab, and infusing them back, this drug delivers genetic instructions directly into the body using tiny f…
Matched conditions: LYMPHOCYTIC LEUKEMIA
Phase: EARLY_PHASE1 • Sponsor: The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC